Report Detail
Global Atezolizumab Market Insights, Forecast to 2025
- RnM2436337 |
- 22 May, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
The global Atezolizumab market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Atezolizumab market based on company, product type, end user and key regions.
This report studies the global market size of Atezolizumab in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Atezolizumab in these regions.
This research report categorizes the global Atezolizumab market by top players/brands, region, type and end user. This report also studies the global Atezolizumab market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Genentech (Roche)
Atezolizumab market size by Type
Use: Single Drug
Use: Chemotherapy Combination
Atezolizumab market size by Applications
Bladder Cancer
Lung Cancer
Advanced Triple-negative Breast Cancer
Head and Neck Cancer
Urothelial Carcinoma
Renal Cell Carcinoma
Hepatocellular Carcinoma (HCC)
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Atezolizumab market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Atezolizumab market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Atezolizumab companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Atezolizumab submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Atezolizumab are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Atezolizumab market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Atezolizumab Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Atezolizumab Market Size Growth Rate by Type
- 1.4.2 Use: Single Drug
- 1.4.3 Use: Chemotherapy Combination
- 1.5 Market by Application
- 1.5.1 Global Atezolizumab Market Size Growth Rate by Application
- 1.5.2 Bladder Cancer
- 1.5.3 Lung Cancer
- 1.5.4 Advanced Triple-negative Breast Cancer
- 1.5.5 Head and Neck Cancer
- 1.5.6 Urothelial Carcinoma
- 1.5.7 Renal Cell Carcinoma
- 1.5.8 Hepatocellular Carcinoma (HCC)
- 1.5.9 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Atezolizumab Market Size
- 2.1.1 Global Atezolizumab Revenue 2014-2025
- 2.1.2 Global Atezolizumab Sales 2014-2025
- 2.2 Atezolizumab Growth Rate by Regions
- 2.2.1 Global Atezolizumab Sales by Regions
- 2.2.2 Global Atezolizumab Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Atezolizumab Sales by Manufacturers
- 3.1.1 Atezolizumab Sales by Manufacturers
- 3.1.2 Atezolizumab Sales Market Share by Manufacturers
- 3.2 Atezolizumab Revenue by Manufacturers
- 3.2.1 Atezolizumab Revenue by Manufacturers (2014-2019)
- 3.2.2 Atezolizumab Revenue Share by Manufacturers (2014-2019)
- 3.3 Atezolizumab Price by Manufacturers
- 3.4 Atezolizumab Manufacturing Base Distribution, Product Types
- 3.4.1 Atezolizumab Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Atezolizumab Product Type
- 3.4.3 Date of International Manufacturers Enter into Atezolizumab Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Atezolizumab Sales by Type
- 4.2 Global Atezolizumab Revenue by Type
- 4.3 Atezolizumab Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Atezolizumab Breakdown Data by Application
6 North America
- 6.1 North America Atezolizumab by Country
- 6.1.1 North America Atezolizumab Sales by Country
- 6.1.2 North America Atezolizumab Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Atezolizumab by Type
- 6.3 North America Atezolizumab by Application
7 Europe
- 7.1 Europe Atezolizumab by Country
- 7.1.1 Europe Atezolizumab Sales by Country
- 7.1.2 Europe Atezolizumab Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Atezolizumab by Type
- 7.3 Europe Atezolizumab by Application
8 Asia Pacific
- 8.1 Asia Pacific Atezolizumab by Country
- 8.1.1 Asia Pacific Atezolizumab Sales by Country
- 8.1.2 Asia Pacific Atezolizumab Revenue by Country
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Atezolizumab by Type
- 8.3 Asia Pacific Atezolizumab by Application
9 Central & South America
- 9.1 Central & South America Atezolizumab by Country
- 9.1.1 Central & South America Atezolizumab Sales by Country
- 9.1.2 Central & South America Atezolizumab Revenue by Country
- 9.1.3 Brazil
- 9.1.4 Argentina
- 9.2 Central & South America Atezolizumab by Type
- 9.3 Central & South America Atezolizumab by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Atezolizumab by Country
- 10.1.1 Middle East and Africa Atezolizumab Sales by Country
- 10.1.2 Middle East and Africa Atezolizumab Revenue by Country
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Atezolizumab by Type
- 10.3 Middle East and Africa Atezolizumab by Application
11 Company Profiles
- 11.1 Genentech (Roche)
- 11.1.1 Genentech (Roche) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Genentech (Roche) Atezolizumab Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Genentech (Roche) Atezolizumab Products Offered
- 11.1.5 Genentech (Roche) Recent Development
12 Future Forecast
- 12.1 Atezolizumab Market Forecast by Regions
- 12.1.1 Global Atezolizumab Sales Forecast by Regions 2019-2025
- 12.1.2 Global Atezolizumab Revenue Forecast by Regions 2019-2025
- 12.2 Atezolizumab Market Forecast by Type
- 12.2.1 Global Atezolizumab Sales Forecast by Type 2019-2025
- 12.2.2 Global Atezolizumab Revenue Forecast by Type 2019-2025
- 12.3 Atezolizumab Market Forecast by Application
- 12.4 North America Atezolizumab Forecast
- 12.5 Europe Atezolizumab Forecast
- 12.6 Asia Pacific Atezolizumab Forecast
- 12.7 Central & South America Atezolizumab Forecast
- 12.8 Middle East and Africa Atezolizumab Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Atezolizumab Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Atezolizumab . Industry analysis & Market Report on Atezolizumab is a syndicated market report, published as Global Atezolizumab Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Atezolizumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
